Michael Wolff Jensen

Michael Wolff Jensen, L.L.M. has served as the Senior Vice President and Chief Legal Officer since June 2013. In addition, Mr. Jensen served as Chairman of our board of directors from January 2008 to May 2021, and as our Acting Chief Financial Officer from May 2008 to June 2013. From October 2010 to June 2013, Mr. Jensen served as Senior Legal Advisor and Head of Partnerships (France) for the renewable business division of Ørsted A/S, the Danish State-owned utility company. Prior to Ascendis Pharma, Mr. Jensen served as Executive Vice President & Chief Financial Officer of LifeCycle Pharma A/S, now known as Veloxis Pharmaceuticals A/S, a publicly traded biotechnology company, from 2003 to 2008. Prior to joining Veloxis, Mr. Jensen served as Senior Vice President & Chief Financial Officer of Genmab A/S, a publicly traded biotechnology company from 2000 to 2003. Mr. Jensen also currently serves as Chairman of the board of directors of VISEN Pharmaceuticals, and Vicore Pharma AB, a publicly traded biotechnology company. Mr. Jensen received an L.L.M. degree from the University of Copenhagen.